Clovis Oncology, Inc. Quarterly Other Assets, Current in USD from Q4 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Clovis Oncology, Inc. quarterly Other Assets, Current history and growth rate from Q4 2011 to Q3 2022.
  • Clovis Oncology, Inc. Other Assets, Current for the quarter ending September 30, 2022 was $7.99M, a 39.4% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $7.99M -$5.19M -39.4% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $11.2M -$1.89M -14.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $16.6M +$2.51M +17.9% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $11.7M +$2.58M +28.2% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 $13.2M -$3.1M -19% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $13.1M -$1.46M -10.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $14.1M -$619K -4.22% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $9.13M -$9.72M -51.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $16.3M -$1.83M -10.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $14.5M -$2.86M -16.5% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $14.7M -$781K -5.05% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $18.8M +$10.2M +119% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $18.1M +$6.32M +53.6% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $17.4M +$9.02M +108% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $15.5M +$6.34M +69.5% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $8.61M +$1.11M +14.8% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $11.8M +$5.87M +99.3% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $8.36M +$1.59M +23.6% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $9.12M +$3.47M +61.5% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $7.5M +$821K +12.3% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $5.91M +$717K +13.8% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $6.77M +$207K +3.16% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $5.65M -$2.45M -30.2% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $6.68M -$1.06M -13.7% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $5.19M -$1.97M -27.4% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $6.56M -$881K -11.8% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $8.09M +$2.83M +53.9% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $7.74M +$3.01M +63.6% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $7.16M -$766K -9.67% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $7.44M +$1.61M +27.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $5.26M +$440K +9.13% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $4.73M +$338K +7.7% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $7.93M +$7.2M +990% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $5.83M +$5.23M +875% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $4.82M +$4.29M +819% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $4.39M +$3.73M +566% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $727K +$349K +92.3% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $598K +$179K +42.7% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $524K -$126K -19.4% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $659K +$412K +167% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $378K Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $419K Jun 30, 2012 10-Q 2012-08-10
Q1 2012 $650K Mar 31, 2012 10-Q 2012-05-11
Q4 2011 $247K Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.